U.S., April 24 -- ClinicalTrials.gov registry received information related to the study (NCT06940011) titled 'Endocalyx in Treatment Resistent Hypertension' on Jan. 20.

Brief Summary: The goal of this randomized, double-blind, placebo-controlled study is to assess whether the food supplement Endocalyx lowers blood pressure in patients with treatment resistant hypertension.

Study Start Date: Jan. 21

Study Type: INTERVENTIONAL

Condition: Treatment Resistant Hypertension

Intervention: DIETARY_SUPPLEMENT: Endocalyx Pro

4 capsules once daily OR 2 capsules twice daily

OTHER: Placebo

4 capsules once daily OR 2 capsules twice daily

Recruitment Status: RECRUITING

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)...